ST variability during the first 4 hours of acute myocardial infarction predicts 1-year mortality

Annals of Noninvasive Electrocardiology

Volumn 6, Issue 3, 2001, Pages 198-202

  Johanson, Per ^a   Swedberg, Karl ^a   Dellborg, Mikael ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Electrocardiography; Myocardial infarction; Reperfusion

Indexed keywords

ALTEPLASE; PLACEBO;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; ST SEGMENT; TREATMENT OUTCOME; VECTORCARDIOGRAPHY;

EID: 0034895325     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2001.tb00108.x     Document Type: Article

References (35)

1. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction
2. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
3. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
4. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET)
5. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients
6. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction
7. Natural history of severe proximal coronary artery disease as documented by coronary cineangiography
8. Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS)
9. Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: Angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis
10. Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?
11. Prevention of myocardial infarction by very early treatment with intracoronary streptokinase. Some clinical observations
12. Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy
13. Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: Prediction of clinical outcome
14. The "no-reflow" phenomenon after temporary coronary occlusion in the dog
15. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction
16. Noninvasive detection of coronary artery patency using continuous ST segment monitoring
17. Vectorcardiographic monitoring to assess early vessel patency after reperfusion therapy for acute myocardial infarction
18. Noninvasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial
19. A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent
20. Prognostic information from on-line vectorcardiography in acute myocardial infarction
21. Extent of early ST segment elevation resolution: A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial
22. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: The GUSTO-I ST Segment Monitoring Substudy
23. Resolution of ST segment elevation in acute myocardial infarction. Early prognostic significance after thrombolytic therapy. Results from the COBALT trial
24. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction
25. The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion
26. Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease
27. Dynamic QRS and ST segment changes in myocardial infarction monitored by continuous on-line vectorcardiography
28. The unstable ST segment early after thrombolysis for acute infarction and its usefulness as a marker of recurrent coronary occlusion
29. Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive patency assessment during acute myocardial infarction
30. Early treatment with thrombolysis and beta-blockade in suspected acute myocardial infarction: Results from the TEAHAT Study
31. Dynamic QRS complex and ST segment monitoring in acute myocardial infarction during recombinant tissue-type plasminogen activator therapy
32. Accurate, clinically practical system for spatial vectorcardiography
33. Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator
34. Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA
35. Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage